Nubeqa Plus Hormone Therapy May Slow Prostate Cancer Progression
Among patients with metastatic hormone-sensitive prostate cancer, the treatment combination of Nubeqa (darolutamide) and androgen deprivation therapy (ADT) has reportedly displayed positive results regarding radiological progression-free survival (the time …